HUBB vs VYGR · P/E 28, rev $1.49B vs rev $5.8M
Hubbell Inc (HUBB) versus Voyager Therapeutics Inc (VYGR) — a side-by-side from cached financials, not a winner call.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Latest reported HUBB revenue for 2025-12-31 was $1.49B. Net income was $224.2M. Revenue was down 73.5% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Latest reported VYGR revenue for 2026-06-30 was $5.8M. Net income was -$52.4M. VYGR currently screens at market cap $225.4M.
HUBB currently screens at market cap $22.14B and trailing P/E 28.0. VYGR currently screens at market cap $225.4M.
Not investment advice. Open the HUBB and VYGR stock pages for the full models.
Not investment advice.